Clozapine pharmacokinetics and pharmacodynamics studied with Cyp1A2-null mice.

@article{Aitchison2000ClozapinePA,
  title={Clozapine pharmacokinetics and pharmacodynamics studied with Cyp1A2-null mice.},
  author={Katherine J Aitchison and Michael W. Jann and Jian-hong Zhao and Toshio Sakai and Hani Zaher and K Wolff and David A. Collier and Robert W. Kerwin and Frank J. Gonzalez},
  journal={Journal of psychopharmacology},
  year={2000},
  volume={14 4},
  pages={353-9}
}
The aim of this study was to use the CYP1A2-null mouse to investigate the in-vivo contribution of CYP1A2 to clozapine pharmacokinetics and pharmacodynamics. An intraperitoneal injection of 10 mg/kg clozapine was administered to four male CYP1A2 -/- mice and four male wild-type mice. Clozapine, desmethylclozapine, and clozapine N-oxide concentrations in sequential tail blood samples were measured by HPLC with UV detection. Behavioural parameters were recorded at each time point. The area under… CONTINUE READING

Similar Papers

Loading similar papers…